Using advanced imaging to better understand liver cancer
Quantitative PET Imaging of Hepatocellular Carcinoma (HCC)
This study is looking at new ways to spot and treat liver cancer using advanced imaging techniques, which could help doctors understand your cancer better and find the best treatment just for you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10923885 on NIH RePORTER |
What this research studies
This research focuses on improving the detection and treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer, by utilizing advanced imaging techniques known as positron emission tomography (PET). Unlike traditional imaging methods that only show the structure of tumors, this study aims to provide insights into the cellular and molecular characteristics of HCC, which could lead to more personalized treatment options. The researchers will evaluate new imaging tracers that may offer better sensitivity for detecting HCC compared to the commonly used 18F-FDG PET. By enhancing the ability to identify and assess liver tumors, this research could significantly impact clinical decision-making for patients with HCC.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with hepatocellular carcinoma or those at high risk for developing liver cancer.
Not a fit: Patients with other types of cancer or those without liver disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and more effective treatment strategies for patients with liver cancer.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for cancer detection, suggesting that this approach could yield significant advancements in liver cancer management.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Manning, Henry Charles — University of Tx Md Anderson Can Ctr
- Study coordinator: Manning, Henry Charles
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.